ÂÜÀòÂÒÂ×

Janelle Goulard is an accomplished professional with extensive experience in health and biotechnology investments. Currently serving as a Partner at Pangaea Ventures since December 2016, Goulard focuses on innovative hard sciences that promote planetary health. In 2024, Goulard took on the role of Director of Health Investment at Kanvas Biosciences and serves as a Board Observer, contributing to advancements in spatial biology for drug discovery. Additionally, Goulard is the Chair of the Board of Directors at Biodel AG, Board Director at Sun Genomics, and an Investor at Aspect Biosystems, showcasing a commitment to improving health outcomes through technology. Goulard's previous roles include Board Director at Modulim and Consulting Manager at Bernelle, further highlighting a diverse background in consulting and private equity. Educational credentials include an MBA in Innovation and Entrepreneurship from The University of British Columbia and a BComm in International Business from McGill University.